|
|
Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort
Jade Ghosn
,
Delphine Bachelet
,
Marine Livrozet
,
Minerva Cervantes-Gonzalez
,
Julien Poissy
,
et al.
Article dans une revue
hal-03801797v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
Yoann Zerbib
,
Yazdan Yazdanpanah
,
Guilhem Wattecamps
,
Florent Wallet
,
Gil Verschelden
,
et al.
Article dans une revue
hal-03687787v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
Florence Ader
,
Nathan Peiffer-Smadja
,
Julien Poissy
,
Maude Bouscambert-Duchamp
,
Drifa Belhadi
,
et al.
Article dans une revue
hal-03364426v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial
Florence Ader
,
Maude Bouscambert-Duchamp
,
Maya Hites
,
Nathan Peiffer-Smadja
,
Julien Poissy
,
et al.
2023
Pré-publication, Document de travail
hal-04117589v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial
Florence Ader
,
Maude Bouscambert-Duchamp
,
Maya Hites
,
Nathan Peiffer-Smadja
,
Julien Poissy
,
et al.
Article dans une revue
hal-04119314v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|